Yixing Jiang

3.4k total citations
81 papers, 1.9k citations indexed

About

Yixing Jiang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yixing Jiang has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 28 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yixing Jiang's work include Gastric Cancer Management and Outcomes (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Yixing Jiang is often cited by papers focused on Gastric Cancer Management and Outcomes (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Yixing Jiang collaborates with scholars based in United States, China and Canada. Yixing Jiang's co-authors include Jaffer A. Ajani, Kevin F. Staveley-O’Carroll, Eric T. Kimchi, William N. Rom, Hua Cheng, Lu‐Hai Wang, Wei Ding, Hanning You, Hien Dang and Keping Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yixing Jiang

77 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yixing Jiang United States 23 975 680 366 312 217 81 1.9k
Guang‐Hui Xiao United States 19 1.1k 1.1× 379 0.6× 327 0.9× 307 1.0× 122 0.6× 23 2.1k
Peizhen Hu China 22 817 0.8× 297 0.4× 316 0.9× 461 1.5× 209 1.0× 55 1.8k
Chundong Yu China 30 2.1k 2.1× 614 0.9× 239 0.7× 479 1.5× 337 1.6× 83 3.0k
Xueyan Wang China 18 1.4k 1.4× 423 0.6× 224 0.6× 380 1.2× 150 0.7× 61 2.0k
Giacomo Manenti Italy 30 1.8k 1.9× 811 1.2× 388 1.1× 590 1.9× 151 0.7× 102 3.0k
Shengyong Yin China 27 1.3k 1.3× 879 1.3× 240 0.7× 603 1.9× 246 1.1× 78 2.7k
Runzhou Ni China 29 1.8k 1.8× 436 0.6× 238 0.7× 711 2.3× 179 0.8× 103 2.4k
Chung‐Liang Ho Taiwan 26 849 0.9× 426 0.6× 280 0.8× 277 0.9× 139 0.6× 70 2.1k
Ramona Graves‐Deal United States 24 1.6k 1.7× 835 1.2× 184 0.5× 559 1.8× 168 0.8× 33 2.6k
Changcun Guo China 27 1.4k 1.4× 451 0.7× 187 0.5× 582 1.9× 305 1.4× 72 2.3k

Countries citing papers authored by Yixing Jiang

Since Specialization
Citations

This map shows the geographic impact of Yixing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixing Jiang more than expected).

Fields of papers citing papers by Yixing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixing Jiang. The network helps show where Yixing Jiang may publish in the future.

Co-authorship network of co-authors of Yixing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yixing Jiang. A scholar is included among the top collaborators of Yixing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixing Jiang. Yixing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Judy S., David Sommerhalder, Manish Sharma, et al.. (2024). Phase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation.. Journal of Clinical Oncology. 42(16_suppl). 2582–2582. 2 indexed citations
2.
Gourdin, Theodore Stewart, et al.. (2023). A phase I study of the ceramide nanoliposome in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 93(1). 23–29. 8 indexed citations
3.
Jiang, Yixing, et al.. (2022). BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities. Molecular Cancer Research. 21(4). 293–300. 16 indexed citations
4.
Bhayani, Neil H., et al.. (2015). Advances in the Pharmacologic Treatment of Hepatocellular Carcinoma. Current Clinical Pharmacology. 10(4). 299–304. 15 indexed citations
5.
6.
Appleman, Leonard J., Sanjeeve Balasubramaniam, Robert A. Parise, et al.. (2014). A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent. Clinical Cancer Research. 21(4). 721–729. 5 indexed citations
7.
Jiang, Yixing. (2012). Multidisciplinary approach for the treatment of gastric cancer. 1(2). 175–177. 2 indexed citations
8.
You, Hanning, et al.. (2011). c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 54(3). 879–889. 167 indexed citations
9.
Jiang, Yixing, Nicole A. DiVittore, James M. Kaiser, et al.. (2011). Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12(7). 574–585. 57 indexed citations
10.
Jiang, Yixing & Jaffer A. Ajani. (2010). Multidisciplinary management of gastric cancer. Current Opinion in Gastroenterology. 26(6). 640–646. 36 indexed citations
11.
Gusani, Niraj J., Jane R. Schubart, James L. Wise, et al.. (2009). Cancer Survivorship: A New Challenge for Surgical and Medical Oncologists. Journal of General Internal Medicine. 24(S2). 456–458. 11 indexed citations
12.
Jiang, Yixing, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Hua Cheng, & Jaffer A. Ajani. (2009). Assessment of K‐ras mutation. Cancer. 115(16). 3609–3617. 57 indexed citations
13.
Yan, Guang Hai, et al.. (2008). Sequestration of NF-κB Signaling Complexes in Lipid Rafts Contributes to Repression of NF-κB in T Lymphocytes under Hyperthermia Stress. Journal of Biological Chemistry. 283(18). 12489–12500. 10 indexed citations
14.
Nikfarjam, Mehrdad, Serene Shereef, Eric T. Kimchi, et al.. (2008). Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy. Annals of Surgical Oncology. 16(7). 1860–1867. 63 indexed citations
15.
Jiang, Yixing, Liwei Wang, Weida Gong, et al.. (2005). A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clinical & Experimental Metastasis. 21(8). 755–764. 66 indexed citations
16.
Buxbaum, Joseph D., L. Georgieva, James Young, et al.. (2002). Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Molecular Psychiatry. 13(2). 162–172. 68 indexed citations
17.
Rom, William N., John G. Hay, Theodore C. Lee, Yixing Jiang, & Kam-Meng Tchou-Wong. (2000). Molecular and Genetic Aspects of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 161(4). 1355–1367. 123 indexed citations
18.
Li, Weiqun, Yixing Jiang, Jiachang Zhang, et al.. (1998). Protein Kinase C-δ Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation. Molecular and Cellular Biology. 18(10). 5888–5898. 70 indexed citations
19.
Zong, Cong S., et al.. (1998). Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth. Journal of Biological Chemistry. 273(43). 28065–28072. 81 indexed citations
20.
Xiong, Qinghua, Xiaojun Guo, Cong S. Zong, et al.. (1996). Cloning and expression of chicken protein tyrosine phosphatase gamma. Journal of Biomedical Science. 3(4). 266–274. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang‐Hui Xiao Breakdown of academic impact, for papers by Peizhen Hu Breakdown of academic impact, for papers by Chundong Yu Breakdown of academic impact, for papers by Xueyan Wang Breakdown of academic impact, for papers by Giacomo Manenti Breakdown of academic impact, for papers by Shengyong Yin Breakdown of academic impact, for papers by Runzhou Ni Breakdown of academic impact, for papers by Chung‐Liang Ho Breakdown of academic impact, for papers by Ramona Graves‐Deal Breakdown of academic impact, for papers by Changcun Guo
Rankless by CCL
2026